Asia Pacific DNA sequencing market will grow by 17.4% annually with a total addressable market cap of $ 75,903.7 million over 2022-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA … Read more
Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for … Read more
North America DNA sequencing market is projected to grow by 14.8% annually in the forecast period and reach $20,330.9 million by 2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA … Read more
Global DNA sequencing market will reach $52,278.1 million by 2031, growing by 15.4% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.Highlighted … Read more
Asia Pacific clinical trials market will grow by 8.2% annually with a total addressable market cap of $104,282.0 million over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as … Read more
Europe clinical trials market was valued at $10,471.1 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and … Read more
North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $ 39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases … Read more
Global clinical trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase … Read more
Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $ 13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the … Read more
North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $ 3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and … Read more